Literature DB >> 5017367

The human secondary immune response to Keyhole limpet haemocyanin.

J E Curtis, E M Hersh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5017367      PMCID: PMC1713091     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  16 in total

1.  Immunosuppressive therapy. The relation between clinical response and immunologic competence.

Authors:  M A Swanson; R S Schwartz
Journal:  N Engl J Med       Date:  1967-07-27       Impact factor: 91.245

2.  Measurement of antibody-producing capacity in man. I. The normal response to flagellin from Salmonella adelaide.

Authors:  M J Rowley; I R Mackay
Journal:  Clin Exp Immunol       Date:  1969-10       Impact factor: 4.330

3.  Skin sensitivity to human, avian and BCG PPDs after BCG vaccination.

Authors:  C J Stewart
Journal:  Tubercle       Date:  1968-03

4.  Tuberculin sensitive lymphocytes in human peripheral blood following Mantoux test.

Authors:  N R Hughes
Journal:  Aust J Exp Biol Med Sci       Date:  1968-10

Review 5.  The kinetics of antibody formation.

Authors:  J W Uhr; M S Finkelstein
Journal:  Prog Allergy       Date:  1967

Review 6.  Natural antibodies and the immune response.

Authors:  S V Boyden
Journal:  Adv Immunol       Date:  1966       Impact factor: 3.543

7.  Antigens in immunity. VII. Analysis of immunological memory.

Authors:  G J Nossal; C M Austin; G L Ada
Journal:  Immunology       Date:  1965-10       Impact factor: 7.397

8.  Immunologic response of atopic and normal individuals to keyhole limpet hemocyanin.

Authors:  J Salvaggio; E Castro-Murillo; V Kundur
Journal:  J Allergy       Date:  1969-12

9.  Antibody formation in dysgammaglobulinemia.

Authors:  G J Gleich; J W Uhr; J H Vaughan; H A Swedlund
Journal:  J Clin Invest       Date:  1966-08       Impact factor: 14.808

10.  Antigenicity of polypeptides (poly-alpha-amino acids). XVII. Immunologic studies in humans with polymers containing L or D and L-alpha-amino acids.

Authors:  P H Maurer
Journal:  J Immunol       Date:  1965-12       Impact factor: 5.422

View more
  12 in total

1.  Distribution and characterization of rhogocyte cell types in the mantle tissue of Haliotis laevigata.

Authors:  Fareed Sairi; Peter Valtchev; Vincent G Gomes; Fariba Dehghani
Journal:  Mar Biotechnol (NY)       Date:  2014-11-11       Impact factor: 3.619

2.  Human immune responses in vivo to protein (KLH) and polysaccharide (DNP-Ficoll) neoantigens: normal subjects compared with bone marrow transplant patients on cyclosporine.

Authors:  P L Amlot; A E Hayes; D Gray; E C Gordon-Smith; J H Humphrey
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

3.  Cells binding the antigen keyhole limpet haemocyanin in the peripheral blood and in the lymphocyte cultures of non-immune and immunized human subjects.

Authors:  E M Hersh; S E Dyre
Journal:  Clin Exp Immunol       Date:  1974-06       Impact factor: 4.330

4.  Response to cutaneous immunization with low-molecular-weight subunit keyhole limpet hemocyanin.

Authors:  Henry Milgrom; Karen Kesler; Margie Byron; Ron Harbeck; Robert Holliday; Donald Y M Leung
Journal:  Int Arch Allergy Immunol       Date:  2011-10-28       Impact factor: 2.749

5.  Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man.

Authors:  M R Downham; T R Auton; A Rosul; H L Sharp; L Sjöström; A Rushton; J P Richards; T G K Mant; S M Gardiner; T Bennett; J F Glover
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

6.  Factors influencing the secondary antibody response to flagellin in man.

Authors:  S Whittingham; J D Buckley; I R Mackay
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

7.  Keyhole limpet hemocyanin immunotherapy of murine bladder cancer.

Authors:  D L Lamm; J I DeHaven; D R Riggs; C Delgra; R Burrell
Journal:  Urol Res       Date:  1993-01

8.  The subclasses of human IgG antibodies against tetanus toxoid.

Authors:  M van der Giessen; O Groenboer-Kempers
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

9.  Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man.

Authors:  J Weits; G C de Gast; T H The; M T Esselink; A M Deelder; M Petrovic; E Mandema
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

10.  Keyhole-limpet haemocyanin (KLH) immunotherapy of murine transitional cell carcinoma.

Authors:  W G Walsh; P Tomashefsky; C A Olsson; R deVere White
Journal:  Urol Res       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.